Early onset of immune-mediated diseases in minority ethnic groups in the UK

Abstract

Background The prevalence of some immune-mediated diseases (IMDs) shows distinct differences between populations of different ethnicities. The aim of this study was to determine if the age at diagnosis of common IMDs also differed between different ethnic groups in the UK, suggestive of distinct influences of ethnicity on disease pathogenesis. Methods This was a population-based retrospective primary care study. Linear regression provided unadjusted and adjusted estimates of age at diagnosis for common IMDs within the following ethnic groups: White, South Asian, African-Caribbean and Mixed-race/Other. Potential disease risk confounders in the association between ethnicity and diagnosis age including sex, smoking, body mass index and social deprivation (Townsend quintiles) were adjusted for. The analysis was replicated using data from UK Biobank (UKB). Results After adjusting for risk confounders, we observed that individuals from South Asian, African-Caribbean and Mixed-race/Other ethnicities were diagnosed with IMDs at a significantly younger age than their White counterparts for almost all IMDs. The difference in the diagnosis age (ranging from 2 to 30 years earlier) varied for each disease and by ethnicity. For example, rheumatoid arthritis was diagnosed at age 49, 48 and 47 years in individuals of African-Caribbean, South Asian and Mixed-race/Other ethnicities respectively, compared to 56 years in White ethnicities. The earlier diagnosis of most IMDs observed was validated in UKB although with a smaller effect size. Conclusion Individuals from non-White ethnic groups in the UK had an earlier age at diagnosis for several IMDs than White adults.

Risk of death, thrombotic and hemorrhagic events in anticoagulated patients with atrial fibrillation and systemic autoimmune diseases: an analysis from a global federated dataset

“…SAD predilects females and usually arises during the adolescence or young adulthood [ 9 ]. The high prevalence of certain ethnicities confirms previous epidemiological studies that have shown that the odds for SAD is higher, and the mean age of disease onset is lower, in Black Africans and Asians compared to Whites [ 10 , 11 ]. The earlier onset of SAD implies a longer exposure to the inflammatory state that eventually favors an early AF onset with potential anticipation of cardiovascular events.…”

Enhanced immune ageing associated with increasing COVID-19 disease severity

“…However our multiple linear regression model revealed that neither multimorbidity nor BMI contributed signi cantly to the IMM-AGE score, instead South Asian ethnicity contributed to 17% of the increase in the IMM-AGE score. Interestingly we have shown recently that South Asians adults develop a broad range of immune-mediated diseases much earlier than white adults, possibly suggesting that their immune systems age more rapidly [44]. Our data thus suggest that the SARS-CoV2 infection itself results in an increase in immune ageing.…”

Autoimmune disorders reported following COVID-19 vaccination: A disproportionality analysis using the WHO database

“…[22] In contrast, our study showed a signi cant relationship between IBD and COVID-19 vaccines, suggesting that this inconsistency in results is due to the distinct in uences of ethnicity on autoimmune responses. [23] AID differs between ethnic groups, and the incidence of IBD in Asian populations is much lower than that in Western populations.…”